Sung-Bae Cho
Chief Executive Officer at CHOA PHARMACEUTICAL CO., LTD.
Net worth: 875 295 $ as of 30/04/2024
Profile
Sung-Bae Cho is currently the President, Co-Chief Executive Officer & Director at ChoA Pharmaceutical Co., Ltd.
He previously worked as the Vice President at Medipharm.
Mr. Cho completed his undergraduate degree at Hanyang University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2023 | 750,000 ( 2.42% ) | 875 295 $ | 30/04/2024 |
Sung-Bae Cho active positions
| Companies | Position | Start |
|---|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 17/10/2014 |
Former positions of Sung-Bae Cho
| Companies | Position | End |
|---|---|---|
Medipharm
 Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Corporate Officer/Principal | - |
Training of Sung-Bae Cho
| Hanyang University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Stock Market
- Insiders
- Sung-Bae Cho
